ANGLE vs Immunicon
ANGLE
The leading experts in cancer cell capture and analysis from liquid biopsies
165 employees · est. 1994 · United Kingdom
Immunicon
Pioneering cell-based diagnostic solutions to empower physicians with timely and accurate cancer insights
est. 1983
Immunicon is the older company (1994 vs 1983).
Side-by-Side Comparison
| Metric | ANGLE | Immunicon |
|---|---|---|
| Founded | ||
| Founded | 1994 | 1983 older |
| Headquarters | ||
| Headquarters | United Kingdom | Not tracked yet |
| Employees | ||
| Employees | 165 | Not tracked yet |
| Industry | ||
| Industry | Biotechnology, Health Care, Medical Devices | Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | Post-IPO Equity | Series F |
| Total Funding | ||
| Total Funding | $29.68M | $53.75M |
| Funding Rounds | ||
| Funding Rounds | 3 | 2 |
| Taxonomy | ||
| Taxonomy | Liquid BiopsyCirculating Tumor CellsMedical Device ManufacturerMicrofluidicsCTC Diagnostic SolutionsFDA Cleared Technology +8 | Cell-based DiagnosticsCancer InsightsDiagnostic ProductsCancer ResearchClinical PracticesTumor Cell Identification +9 |
| Website | ||
| Website | angleplc.com | immunicon.com |
About ANGLE
ANGLE, the leading experts in cancer cell capture and analysis from liquid biopsies, is a world-leading liquid biopsy company specializing in innovative circulating tumor cell (CTC) diagnostic solutions. ANGLE's FDA cleared and patent-protected circulating tumor cell (CTC) harvesting technology, the...
About Immunicon
Immunicon, a pioneer in cell-based diagnostic solutions, is revolutionizing the field of cancer diagnosis and treatment. The company's flagship product, CellTracks, enables the identification, counting, and characterization of tumor cells in blood samples, providing crucial insights to physicians an...
Also comparing in this category
Comparing more than these two?
Get ANGLE, Immunicon and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.
How does ANGLE compare?
A PDF of ANGLE and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Rival Readout
Comparing competitors? We do this properly.
10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.
Frequently Asked Questions
Compare ANGLE with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at ANGLE on 14 Sep 2024, and Immunicon on 21 Jun 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
